New Sementis CEO to Advance Vaccine Technology
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the...
Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.
Read more at News-Medical.Net here.
Read more at biorXiv here.